Skin Cancer and Other Dermatologic Conditions Among US Veterans

IMPORTANCE: US veterans may be at an increased risk of developing various dermatologic conditions compared with nonveterans. OBJECTIVES: To compare the prevalence and the odds of dermatologic conditions (eg, skin cancers, dermatitis/eczema/rash, psoriasis) between veterans and nonveterans. DESIGN, S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of dermatology (1960) 2024-10, Vol.160 (10), p.1107-1111
Hauptverfasser: Rezaei, Shawheen J, Kim, Jiyeong, Onyeka, Sonia, Swetter, Susan M, Weinstock, Martin A, Asch, Steven M, Linos, Eleni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:IMPORTANCE: US veterans may be at an increased risk of developing various dermatologic conditions compared with nonveterans. OBJECTIVES: To compare the prevalence and the odds of dermatologic conditions (eg, skin cancers, dermatitis/eczema/rash, psoriasis) between veterans and nonveterans. DESIGN, SETTING, AND PARTICIPANTS: This population-based cross-sectional study leveraged nationally representative data from the National Health and Nutrition Examination Survey (NHANES). Three questionnaires (demographics, medical conditions, and dermatology) were merged from 1999-2018 for analysis. Participants were nonveterans and veterans from NHANES data. Data were analyzed from August 2023 to April 2024. MAIN OUTCOMES AND MEASURES: The prevalence and odds ratios (ORs) comparing veterans and nonveterans were examined for various dermatologic conditions, including self-reported skin cancer history (any skin cancer, melanoma, nonmelanoma and unknown subtypes), dermatitis/eczema/inflamed rash, and psoriasis. RESULTS: In a total of 61 307 participants (54 554 nonveterans and 6753 veterans), there was a higher prevalence of any skin cancer history among US veterans compared with nonveterans (9.0% vs 2.9%; P 
ISSN:2168-6068
2168-6084
2168-6084
DOI:10.1001/jamadermatol.2024.3043